Clinical Trial Update: MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

View source ↗

Summary

A terminated clinical trial evaluating MRI and blood biomarkers for predicting neurocognitive decline after brain radiation in patients with brain neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Brain Neoplasm | Status: TERMINATED